EUVIMEDEUVIMED entdecken
Open Access

Reduced podocyte stiffness is a feature of proteinuric kidney disease

Luisa Ulloa Severino, Xiaolin He, Aditya Mandapati, Tianzhou Zhang, Sri Nagarjun Batchu, Vatsal Sachan, Julian Kennedy, Kendrix Kek, Adriana Krizova, Franziska Lausecker, Christopher Yip, Andrew Advani und 4 weitere

Kidney International · 2026-07 · 110 (1) · 145-160

DOI: 10.1016/j.kint.2026.02.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2026-07. Verfasst von Luisa Ulloa Severino und 15 weiteren Autor:innen. Beteiligte Einrichtung: Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital (Unity Health Toronto), Toronto, Ontario, Cana…. Hauptthemen laut MEDLINE: Podocytes, Proteinuria, Glomerulosclerosis, Focal Segmental, Kidney Glomerulus. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Proteinuria is a common and important manifestation of glomerular injury. Although the molecular events driving proteinuria have been studied extensively, the biomechanical changes that occur in the glomerulus remain largely unexplored. METHODS: Using in situ atomic force microscopy on kidney tissue from murine glomerular disease models (Akita+/- Ren+/-, Col4a5-/Y, and Myo1e-/- vs controls) and human biopsies (focal segmental glomerulosclerosis vs transplant donors as controls), the stiffness of glomeruli, podocytes, and glomerular basement membranes was analyzed. We also measured the expression and/or localization of beta1 integrin and the two mechanosensitive transcription co-factor proteins YAP and TAZ using immunofluorescence staining. RESULTS: We show that the stiffness of glomeruli and various glomerular components changes in response to various forms of kidney injury. These changes are often opposing in nature and likely reflect underlying disease-specific processes. Our case-control studies revealed that podocyte softening is a common feature of proteinuric kidney diseases in humans and mice, even when podocytes sit upon a thickened and stiffer glomerular basement membrane. Furthermore, in the setting of proteinuria, podocytes express lower levels of beta1 integrin, a critical molecule used by podocytes to adhere to the glomerular basement membrane. Moreover, beta1 integrin inhibition results in podocyte softening, and this softening is associated with inactivation of YAP and TAZ, two mechanosensitive transcription co-factors that are critical for maintaining podocyte health. Finally, YAP/TAZ inhibition leads to lower beta1 integrin expression. CONCLUSIONS: Our results demonstrate that glomeruli and their components undergo dramatic and often divergent stiffness changes following different types of injury. Interestingly, podocyte softening is a common manifestation of proteinuric kidney diseases, a phenomenon that is associated with inactivation of transcription co-factors that maintain normal podocyte structure and function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodocytesProteinuriaGlomerulosclerosis, Focal SegmentalKidney GlomerulusAnimalsHumansIntegrin beta1Adaptor Proteins, Signal TransducingDisease Models, AnimalYAP-Signaling ProteinsGlomerular Basement MembraneMicroscopy, Atomic ForceCase-Control StudiesMaleCell Cycle ProteinsFemaleMiceMice, KnockoutTrans-ActivatorsCollagen Type IVBiopsy

Stichwörter der Autor:innen

kidney diseasepodocyteproteinuriastiffness

Substanzen

Integrin beta1Adaptor Proteins, Signal TransducingYAP-Signaling ProteinsYap1 protein, mouseYAP1 protein, humanCell Cycle ProteinsTrans-ActivatorsItgb1 protein, mouseCollagen Type IV

Autor:innen und Institutionen

  • Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital (Unity Health Toronto), Toronto, Ontario, Canada.
  • Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital (Unity Health Toronto) and University of Toronto, Toronto, Ontario, Canada.
  • Manchester Cell-Matrix Centre, Division of Cell-Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, the University of Manchester, Manchester Academic Health S…
  • Faculty of Applied Science and Engineering, University of Toronto, Toronto, Ontario, Canada.
  • Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital (Unity Health Toronto), Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, C…
  • Cell and Developmental Biology Department, State University of New York Upstate Medical University, Syracuse, New York, USA.

Förderung

  • Wellcome Trust
  • NIDDK NIH HHS
  • National Institutes of Health
  • Canadian Institutes of Health Research
  • Wellcome
  • Canada Research Chairs Program
  • St Michael's Hospital Foundation
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Severino, L. U., He, X., Mandapati, A., Zhang, T., Batchu, S. N., Sachan, V., Kennedy, J., Kek, K., Krizova, A., Lausecker, F., Yip, C., Advani, A., Lennon, R., Chase, S. E., Krendel, M., & Yuen, D. A. (2026). Reduced podocyte stiffness is a feature of proteinuric kidney disease. Kidney International, 110(1), 145-160. https://doi.org/10.1016/j.kint.2026.02.028

Vancouver

Severino LU, He X, Mandapati A, Zhang T, Batchu SN, Sachan V, et al. Reduced podocyte stiffness is a feature of proteinuric kidney disease. Kidney International. 2026;110(1):145-160. doi:10.1016/j.kint.2026.02.028

BibTeX
@article{Severino2026,
  author = {Severino, Luisa Ulloa and He, Xiaolin and Mandapati, Aditya and Zhang, Tianzhou and Batchu, Sri Nagarjun and Sachan, Vatsal and Kennedy, Julian and Kek, Kendrix and Krizova, Adriana and Lausecker, Franziska and Yip, Christopher and Advani, Andrew and Lennon, Rachel and Chase, Sharon E and Krendel, Mira and Yuen, Darren A},
  title = {Reduced podocyte stiffness is a feature of proteinuric kidney disease},
  journal = {Kidney International},
  year = {2026},
  volume = {110},
  number = {1},
  pages = {145--160},
  doi = {10.1016/j.kint.2026.02.028}
}
Kostenlos starten →